NZ704247A - Compositions and treatment for eye diseases and disorders - Google Patents
Compositions and treatment for eye diseases and disordersInfo
- Publication number
- NZ704247A NZ704247A NZ704247A NZ70424713A NZ704247A NZ 704247 A NZ704247 A NZ 704247A NZ 704247 A NZ704247 A NZ 704247A NZ 70424713 A NZ70424713 A NZ 70424713A NZ 704247 A NZ704247 A NZ 704247A
- Authority
- NZ
- New Zealand
- Prior art keywords
- disorders
- compositions
- eye diseases
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261676530P | 2012-07-27 | 2012-07-27 | |
| US201361756321P | 2013-01-24 | 2013-01-24 | |
| PCT/US2013/052264 WO2014018856A1 (en) | 2012-07-27 | 2013-07-26 | Compositions and treatment for eye diseases and disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ704247A true NZ704247A (en) | 2018-04-27 |
Family
ID=49997851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ704247A NZ704247A (en) | 2012-07-27 | 2013-07-26 | Compositions and treatment for eye diseases and disorders |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20150216877A1 (show.php) |
| EP (1) | EP2877184B1 (show.php) |
| JP (1) | JP6209777B2 (show.php) |
| KR (1) | KR102097663B1 (show.php) |
| CN (2) | CN104661663A (show.php) |
| AU (1) | AU2013295645B2 (show.php) |
| BR (1) | BR112015001847A8 (show.php) |
| CA (1) | CA2880027C (show.php) |
| DK (1) | DK2877184T3 (show.php) |
| ES (1) | ES2759781T3 (show.php) |
| HU (1) | HUE046963T2 (show.php) |
| IL (1) | IL236920B (show.php) |
| IN (1) | IN2015DN00542A (show.php) |
| MX (1) | MX362185B (show.php) |
| NZ (1) | NZ704247A (show.php) |
| PL (1) | PL2877184T3 (show.php) |
| PT (1) | PT2877184T (show.php) |
| SM (1) | SMT201900678T1 (show.php) |
| WO (1) | WO2014018856A1 (show.php) |
| ZA (1) | ZA201500561B (show.php) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| JP6317805B2 (ja) | 2013-03-15 | 2018-04-25 | グリア エルエルシーGlia, Llc | 局所用プロゲステロン組成物 |
| WO2015080758A1 (en) * | 2013-11-27 | 2015-06-04 | Al-Qahtani Ahmed H | Method and composition for the treatment of moderate to severe keratoconjunctivitis sicca |
| WO2015179782A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP3171872B1 (en) | 2014-07-21 | 2020-11-11 | Glia, LLC | Method for treating radiotherapy-and-chemotherapy associated cognitive or emotional impairment with cannabinoids |
| KR20170040209A (ko) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 경피 크림 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| KR101960023B1 (ko) * | 2016-12-21 | 2019-03-20 | 김보경 | 이산화탄소 발생 장치 |
| CA3167771A1 (en) * | 2020-02-12 | 2021-08-19 | Glia, Llc | Progesterone combinations |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5102656A (en) | 1983-07-29 | 1992-04-07 | The Mennen Company | Antiperspirant creams |
| US4937069A (en) | 1985-11-15 | 1990-06-26 | Bristol-Myers Squibb Company | Anhydrous semi-solid antiperspirant suspension |
| US5069897A (en) | 1987-10-16 | 1991-12-03 | The Proctor & Gamble Company | Antiperspirant creams |
| US6659985B2 (en) | 2002-01-30 | 2003-12-09 | Southern College Of Optometry | Method to use transdermal administration of androgens to the adnexa of the eye |
| US7572780B2 (en) * | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
| US20080132475A1 (en) * | 2006-12-05 | 2008-06-05 | Charles Gerald Connor | Treatment for dry eye |
| AU2008309923B2 (en) | 2007-10-08 | 2014-04-03 | Fovea Pharmaceuticals | Aqueous ophthalmic formulations |
| US20100016264A1 (en) * | 2007-12-05 | 2010-01-21 | Connor Charles G | Treatment for dry eye using testosterone and progestagen |
| CN101757622A (zh) * | 2008-11-28 | 2010-06-30 | 天津金耀集团有限公司 | 一种眼部抗炎的药物组合物 |
| EP2482788B1 (en) * | 2009-10-02 | 2022-12-14 | Journey Medical Corporation | Topical tetracycline compositions |
-
2013
- 2013-07-26 BR BR112015001847A patent/BR112015001847A8/pt not_active Application Discontinuation
- 2013-07-26 PL PL13823485T patent/PL2877184T3/pl unknown
- 2013-07-26 CA CA2880027A patent/CA2880027C/en active Active
- 2013-07-26 NZ NZ704247A patent/NZ704247A/en unknown
- 2013-07-26 PT PT138234851T patent/PT2877184T/pt unknown
- 2013-07-26 DK DK13823485T patent/DK2877184T3/da active
- 2013-07-26 WO PCT/US2013/052264 patent/WO2014018856A1/en not_active Ceased
- 2013-07-26 AU AU2013295645A patent/AU2013295645B2/en active Active
- 2013-07-26 CN CN201380039713.2A patent/CN104661663A/zh active Pending
- 2013-07-26 ES ES13823485T patent/ES2759781T3/es active Active
- 2013-07-26 IN IN542DEN2015 patent/IN2015DN00542A/en unknown
- 2013-07-26 US US14/417,640 patent/US20150216877A1/en not_active Abandoned
- 2013-07-26 KR KR1020157004782A patent/KR102097663B1/ko active Active
- 2013-07-26 CN CN201710063950.2A patent/CN107595857A/zh active Pending
- 2013-07-26 JP JP2015524465A patent/JP6209777B2/ja active Active
- 2013-07-26 MX MX2015001250A patent/MX362185B/es active IP Right Grant
- 2013-07-26 EP EP13823485.1A patent/EP2877184B1/en active Active
- 2013-07-26 SM SM20190678T patent/SMT201900678T1/it unknown
- 2013-07-26 HU HUE13823485A patent/HUE046963T2/hu unknown
-
2015
- 2015-01-25 IL IL236920A patent/IL236920B/en active IP Right Grant
- 2015-01-26 ZA ZA2015/00561A patent/ZA201500561B/en unknown
-
2016
- 2016-12-15 US US15/380,741 patent/US9925201B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2877184B1 (en) | 2019-09-04 |
| IL236920B (en) | 2018-06-28 |
| MX362185B (es) | 2019-01-08 |
| CA2880027C (en) | 2021-12-07 |
| MX2015001250A (es) | 2015-10-22 |
| PT2877184T (pt) | 2019-12-02 |
| CN107595857A (zh) | 2018-01-19 |
| KR102097663B1 (ko) | 2020-04-06 |
| PL2877184T3 (pl) | 2020-04-30 |
| ES2759781T3 (es) | 2020-05-12 |
| DK2877184T3 (da) | 2019-12-09 |
| CN104661663A (zh) | 2015-05-27 |
| KR20150038311A (ko) | 2015-04-08 |
| HK1210968A1 (en) | 2016-05-13 |
| JP2015524434A (ja) | 2015-08-24 |
| JP6209777B2 (ja) | 2017-10-11 |
| US20150216877A1 (en) | 2015-08-06 |
| AU2013295645B2 (en) | 2017-08-24 |
| HUE046963T2 (hu) | 2020-04-28 |
| AU2013295645A1 (en) | 2015-02-05 |
| EP2877184A1 (en) | 2015-06-03 |
| BR112015001847A2 (pt) | 2017-07-04 |
| ZA201500561B (en) | 2016-04-28 |
| US9925201B2 (en) | 2018-03-27 |
| CA2880027A1 (en) | 2014-01-30 |
| BR112015001847A8 (pt) | 2021-09-08 |
| WO2014018856A1 (en) | 2014-01-30 |
| SMT201900678T1 (it) | 2020-03-13 |
| EP2877184A4 (en) | 2016-03-30 |
| IN2015DN00542A (show.php) | 2015-06-26 |
| US20170189413A1 (en) | 2017-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ704247A (en) | Compositions and treatment for eye diseases and disorders | |
| UA114705C2 (uk) | Андрогенна композиція для лікування офтальмологічного захворювання | |
| MY171920A (en) | Prevention and treatment of ocular conditions | |
| HK1258588A1 (zh) | 用於治療眼科疾病的化合物和製劑 | |
| BR112015018438A2 (pt) | anticorpo contra c5 e método para prevenir e tratar doenças relacionadas a complemento | |
| PH12014502449A1 (en) | Methods for the treatment of diabetic retinopathy and other ophthalmic diseases | |
| MX386895B (es) | Formulaciones oculares para suministro de farmaco al segmento posterior del ojo | |
| EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
| MX361858B (es) | Formulación oftálmica de lípido polioxilo o de ácido graso polioxilo y tratamiento de padecimientos oculares. | |
| MY181828A (en) | Bicyclically substituted uracils and the use therapy | |
| MY170198A (en) | Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof | |
| WO2012080497A3 (en) | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases | |
| DK2714888T3 (da) | Rekombinant gær | |
| PH12014500967A1 (en) | A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent | |
| NZ704178A (en) | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions | |
| EP4420722A3 (en) | Modified fibroblast growth factors for the treatment of ocular disorders | |
| MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| MX2015008676A (es) | Formulaciones de nanoparticulas de metadichol, liquidas y en gel. | |
| ZA202003944B (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| PH12015501538A1 (en) | Topical ocular analgesic agents | |
| HK1219654A1 (zh) | 用於治疗眼科疾病和病症的方法 | |
| BR112015007095A2 (pt) | derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados | |
| MX358072B (es) | Composiciones tópicas que comprenden diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que involucran un aumento del dolor. | |
| MX2014000870A (es) | Composiciones farmaceuticas que comprenden 4-bromo-n-(imidazolidin -2-iliden)-1h-benzimidazol-5-amina para tratar enfermedades de la retina. | |
| MX2015004806A (es) | Composiciones y metodos para el tratamiento de la enfermedad de parkinson. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: GLIA LLC, US Effective date: 20170821 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2020 BY COMPUTER PACKAGES INC Effective date: 20190718 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2021 BY COMPUTER PACKAGES INC Effective date: 20200701 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2022 BY COMPUTER PACKAGES INC Effective date: 20210630 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2023 BY COMPUTER PACKAGES INC Effective date: 20220717 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2024 BY COMPUTER PACKAGES INC Effective date: 20230630 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2025 BY COMPUTER PACKAGES INC Effective date: 20250101 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2026 BY COMPUTER PACKAGES INC Effective date: 20250930 |